Israel Englander Kamada LTD Transaction History

Millennium Management LLC

$224 Billion
Q1 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Kamada LTD stock. As of the latest transaction made, Millennium Management LLC holds 34,762 shares of KMDA stock, worth $172,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,762

Previous 50,273 30.85%

Holding current value

$172,419

Previous $307,000 36.48%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$5.58 - $6.42 $86,551 - $99,580	-15,511 Reduced 30.85%	34,762 $195,000
Q4 2023 Feb 14, 2024	SELL	$4.14 - $6.22 $42,642 - $64,066	-10,300 Reduced 17.0%	50,273 $307,000
Q2 2023 Aug 14, 2023	SELL	$4.48 - $5.53 $285,949 - $352,968	-63,828 Reduced 51.31%	60,573 $319,000
Q1 2023 May 15, 2023	BUY	$4.12 - $5.25 $189,548 - $241,536	46,007 Added 58.69%	124,401 $576,000
Q4 2022 Feb 14, 2023	BUY	$3.79 - $4.7 $297,113 - $368,451	78,394 New	78,394 $314,000

Q3 2021 Nov 15, 2021	SELL	$5.25 - $5.87 $65,509 - $73,245	-12,478 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$5.67 - $6.33 $70,750 - $78,985	12,478 New	12,478 $73,000
Q1 2021 May 17, 2021	SELL	$6.02 - $8.06 $354,740 - $474,951	-58,927 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$6.3 - $8.46 $260,316 - $349,567	41,320 Added 234.68%	58,927 $382,000
Q3 2020 Nov 16, 2020	BUY	$8.02 - $11.73 $141,208 - $206,530	17,607 New	17,607 $147,000
Q4 2017 Feb 14, 2018	SELL	$4.35 - $5.15 $80,605 - $95,429	-18,530 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.25 - $4.8 $78,752 - $88,944	18,530	18,530 $89,000

Others Institutions Holding KMDA

# of Institutions

Shares Held

5.67M

Call Options Held

300

Put Options Held

151K

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $222M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account